Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration

NCT01014468 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: Ranibizumab (Intravitreal injection)
DRUG: Bevacizumab (Intravitreal injection)

Sponsor

Instituto de Olhos de Goiania